Publications by authors named "Andrew M Evens"

100Publications

Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.

J Clin Oncol 2020 Oct 8:JCO2002668. Epub 2020 Oct 8.

Departments of Pediatrics and Medicine, Tufts University School of Medicine; and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.02668DOI Listing
October 2020

Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.

Curr Oncol Rep 2020 Aug 17;22(11):113. Epub 2020 Aug 17.

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ, 08903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-00972-1DOI Listing
August 2020

Current Treatment Options for Older Patients with Hodgkin Lymphoma.

Curr Treat Options Oncol 2020 04 23;21(5):42. Epub 2020 Apr 23.

Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ, 08903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-020-00745-9DOI Listing
April 2020

A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.

Leuk Lymphoma 2020 07 26;61(7):1555-1564. Epub 2020 Feb 26.

Myeloma and Lymphoma Division, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1731497DOI Listing
July 2020

Management of older Hodgkin lymphoma patients.

Hematology Am Soc Hematol Educ Program 2019 12;2019(1):233-242

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/hematology.2019000028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913478PMC
December 2019

Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.

Br J Haematol 2020 01 26;188(2):295-308. Epub 2019 Aug 26.

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16160DOI Listing
January 2020

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma.

Oncotarget 2019 Mar 12;10(21):2030-2040. Epub 2019 Mar 12.

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26771
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459346PMC
March 2019

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2019 06 11;104(2):436-446. Epub 2019 Feb 11.

Department of Radiation Oncology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.02.007DOI Listing
June 2019

Important new developments in Hodgkin Lymphoma.

Authors:
Andrew M Evens

Br J Haematol 2019 01;184(1)

Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15736DOI Listing
January 2019

Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.

J Control Release 2019 02 12;295:21-30. Epub 2018 Dec 12.

Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01683659183070
Publisher Site
http://dx.doi.org/10.1016/j.jconrel.2018.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396303PMC
February 2019

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

J Clin Oncol 2018 10 4;36(30):3015-3022. Epub 2018 Sep 4.

Andrew M. Evens, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Ranjana H. Advani, Stanford University, Stanford, CA; Irene B. Helenowski, Borko D. Jovanovic, Jane N. Winter, and Leo I. Gordon, Northwestern University Feinberg School of Medicine; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center; Sonali M. Smith, University of Chicago, Chicago, IL; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Gregory R. Bociek, University of Nebraska, Omaha, NE; Andreas K. Klein, Tufts Medical Center, Boston, MA; and Paul A. Hamlin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0139DOI Listing
October 2018

Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?

Lancet Haematol 2018 05 9;5(5):e186-e187. Epub 2018 Apr 9.

Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30049-8DOI Listing
May 2018

Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.

Nat Commun 2018 02 26;9(1):829. Epub 2018 Feb 26.

Department of Medicine, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-03028-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827760PMC
February 2018

Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.

Leuk Lymphoma 2018 08 7;59(8):1976-1980. Epub 2017 Dec 7.

a Division for Hematology/Oncology , Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1406086DOI Listing
August 2018

A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.

PLoS One 2017 20;12(1):e0170521. Epub 2017 Jan 20.

Division of Hematology/Oncology, Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170521PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249061PMC
August 2017

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

J Natl Cancer Inst 2017 04 31;109(4). Epub 2016 Dec 31.

Affiliations of authors: NYU Perlmutter Cancer Center, New York, NY (CSD); BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada (JMC); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY (JWF); Department of Medicine, Weil Cornell University, New York, NY (JPL); Oncology Division, Department of Medicine, Washington University, St. Louis, MO (BSK, NLB); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), Tufts Cancer Center and Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA (AME); Stanford Cancer Institute, Stanford University Medical School, Stanford, CA (RTH); Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Medical Center, New York, NY (KMK); Department of Medicine, University of Arizona Cancer Center, Tucson, AZ (DOP); Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY (AY); Department of Radiology, Mount Sinai Hospital, New York, NY (LK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059238PMC
April 2017

Gray Zone Lymphoma: Current Diagnosis and Treatment Options.

Hematol Oncol Clin North Am 2016 Dec;30(6):1251-1260

Division of Hematology/Oncology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.07.006DOI Listing
December 2016

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.

Clin Lymphoma Myeloma Leuk 2016 12 17;16(12):684-692.e3. Epub 2016 Sep 17.

Division of Hematology/Oncology, Department of Internal Medicine, Tufts University School of Medicine, Boston, MA; Division of Hematology/Oncology, Department of Internal Medicine, Tufts Cancer Center, Boston, MA; Department of Internal Medicine, Tufts Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402751PMC
December 2016

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.

Oncotarget 2016 Sep;7(37):59976-59986

Department of Pathology, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312363PMC
September 2016

Health-related quality of life in Hodgkin lymphoma: a systematic review.

Health Qual Life Outcomes 2016 Jul 29;14(1):114. Epub 2016 Jul 29.

Tufts Cancer Center, Tufts Medical Center, 800 Washington Street, #245, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-016-0515-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966803PMC
July 2016

How I manage patients with grey zone lymphoma.

Br J Haematol 2016 08 15;174(3):345-50. Epub 2016 Jun 15.

Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14174DOI Listing
August 2016

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

J Clin Oncol 2016 06 11;34(17):2020-7. Epub 2016 Apr 11.

Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of Arizona, Tucson, AZ; Nancy L. Bartlett and Brad S. Kahl, Washington University School of Medicine, St. Louis, MO; Andrew M. Evens, Tufts Medical Center; Ann S. LaCasce, Dana-Farber Cancer Institute, Boston, MA; Erik S. Mittra, Stanford University Medical Center, Stanford, CA; John W. Sweetenham, Huntsman Cancer Hospital, Salt Lake City, UT; Michelle A. Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Michael V. Knopp, The Ohio State University, Columbus; Eric D. Hsi, Cleveland Clinic Foundation; James R. Cook, Cleveland Clinic, Cleveland, OH; Mary Jo Lechowicz, Winship Cancer Institute of Emory University, Atlanta, GA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC; Bruce D. Cheson, Georgetown University Hospital, Washington DC; and Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966513PMC
June 2016

The evolving role of response-adapted PET imaging in Hodgkin lymphoma.

Ther Adv Hematol 2016 Apr;7(2):108-25

Division of Hematology-Oncology, Director, Tufts Cancer Center, Tufts Medical Center, 800 Washington Street, Box #245, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715625615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802505PMC
April 2016

The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks.

Cancer Inform 2015 10;14:141-8. Epub 2015 Dec 10.

Director, Tufts Cancer Center, and Chief, Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA. ; Professor of Medicine, Tufts University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S34144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676434PMC
December 2015

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting.

J Clin Oncol 2016 Feb 30;34(5):501-8. Epub 2015 Nov 30.

Michael Lishner, Meir Medical Center, Kfar Saba, and Tel Aviv University; Irit Avivi, Ichilov Medical Center, Tel Aviv, Israel; Jane F. Apperley, Hammersmith Hospital; Susan Robinson, Guy's and St Thomas' National Health Service Foundation Trust, London; Frank Van den Heuvel, University of Oxford, Oxford, United Kingdom; Andrew M. Evens, Tufts Medical Center, Boston, MA; Monica Fumagalli, University of Milan; Fedro Alessandro Peccatori, European Institute of Oncology, Milan, Italy; Irena Nulman, University of Toronto, and The Hospital for Sick Children, Toronto, Ontario, Canada; Fuat S. Oduncu, University of Munich, Munich, Germany; Kristel Van Calsteren, University Hospital Gasthuisberg; Tineke Vandenbroucke and Frederic Amant, Katholieke Universiteit Leuven; Daan Dierickx, University of Leuven; and Tineke Vandenbroucke, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.4445DOI Listing
February 2016

Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue.

J Radiat Res 2015 Sep 7;56(5):792-803. Epub 2015 Aug 7.

Center of Cancer Systems Biology, Tufts University School of Medicine, Boston, MA, USA Molecular Oncology Research Institute, Tufts Medical Center, Tufts Cancer Center, Tufts University School of Medicine, Boston, MA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jrr/rrv043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577010PMC
September 2015

A Clinico-Pathologic Correlation. Burkitt's lymphoma).

J Mass Dent Soc 2015 ;64(1):34-6

View Article

Download full-text PDF

Source
August 2015

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities.

Blood 2015 Apr 3;125(16):2471-6. Epub 2015 Mar 3.

Division of Hematology/Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-11-567792DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467884PMC
April 2015

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):135-43. Epub 2014 Nov 18.

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.135DOI Listing
December 2014

Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder.

Ann Hematol 2015 May 18;94(5):893-4. Epub 2014 Dec 18.

Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, 800 Washington Street, Boston, MA, 02111, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2277-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831911PMC
May 2015

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

Blood 2014 Nov;124(23):3356-64

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-05-57
Publisher Site
http://dx.doi.org/10.1182/blood-2014-05-577627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467863PMC
November 2014

The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Clin Cancer Res 2014 Dec 14;20(23):6023-33. Epub 2014 Oct 14.

Molecular Oncology Research Institute and Division of Hematology Oncology, Tufts Medical Center, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281835PMC
December 2014

Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.

Clin Cancer Res 2015 Jan 9;21(1):113-22. Epub 2014 Jul 9.

Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286476PMC
January 2015

FDG-PET imaging for Hodgkin lymphoma: current use and future applications.

Clin Adv Hematol Oncol 2014 Jan;12(1):20-35

Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
January 2014

Multiple successful desensitizations to brentuximab vedotin: a case report and literature review.

J Natl Compr Canc Netw 2014 Apr;12(4):465-71

From the aDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; bDivision of Hematology/Oncology, Tufts University School of Medicine, Tufts Medical Center, Boston, Massachusetts; and cDivision of Hematology/Oncology, Northwestern University Feinberg School of Medicine, dRobert H. Lurie Comprehensive Cancer Center of Northwestern University, and eDivision of Allergy/Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0052DOI Listing
April 2014

The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras.

Am J Hematol 2014 Jun 10;89(6):633-8. Epub 2014 Apr 10.

Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23708DOI Listing
June 2014

Chemotherapeutic advancements in peripheral T-cell lymphoma.

Semin Hematol 2014 Jan 14;51(1):17-24. Epub 2013 Nov 14.

Division of Hematology and Oncology, Department of Medicine, Tufts University School of Medicine, Medford, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.006DOI Listing
January 2014

Paradoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphoma.

PLoS One 2013 27;8(11):e81333. Epub 2013 Nov 27.

Department of Medicine, Division of Hematology/Oncology Northwestern University Feinberg School of Medicine and the Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081333PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842257PMC
December 2014

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

J Clin Oncol 2013 Nov 16;31(32):4132-9. Epub 2013 Sep 16.

Andrew M. Evens, Tufts University School of Medicine, Boston; Aimee Kroll-Desrosiers, University of Massachusetts Medical School, Worcester, MA; Ranjana Advani and Stavroula Otis, Stanford University Medical Center, Stanford, CA; Oliver W. Press and Linda M. Parker, Fred Hutchinson Cancer Research Center, Seattle, WA; Izidore S. Lossos, Liat Nadav Dagan, and Jose Sandoval, University of Miami School of Medicine, Miami, FL; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Francisco J. Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Ramsey Abdallah and John P. Leonard, Weill Cornell Medical College, New York, NY; Barrett K. Robinson, Indiana University School of Medicine, Indianapolis, IN; Jessica L. Yarber and Leo I. Gordon, Northwestern University Feinberg School of Medicine, Chicago, IL; Kristie A. Blum, The Ohio State University, Columbus, OH; Christopher R. Flowers, Emory University, Atlanta, GA; Thomas M. Habermann, Mayo Clinic, Rochester, MN; and Nancy L. Bartlett, Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.8220DOI Listing
November 2013

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.

Br J Haematol 2013 Oct 8;163(1):55-61. Epub 2013 Aug 8.

Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12488DOI Listing
October 2013

Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma.

Br J Haematol 2013 Nov 2;163(3):352-6. Epub 2013 Aug 2.

Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Health Studies, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12512
Publisher Site
http://dx.doi.org/10.1111/bjh.12512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797194PMC
November 2013

XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.

Hematol Oncol 2013 Jun;31 Suppl 1:69-75

Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2070DOI Listing
June 2013

Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.

Curr Hematol Malig Rep 2013 Sep;8(3):173-83

Division of Hematology/Oncology, The University of Massachusetts Medical School, Worcester, 01568, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-013-0162-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831913PMC
September 2013

How can outcomes be improved for older patients with Hodgkin lymphoma?

J Clin Oncol 2013 Apr 18;31(12):1502-5. Epub 2013 Mar 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.3058DOI Listing
April 2013

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.

Leuk Lymphoma 2013 Mar 11;54(3):497-502. Epub 2012 Sep 11.

Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.722215DOI Listing
March 2013

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Curr Treat Options Oncol 2012 Mar;13(1):122-36

The University of Massachusetts Medical School, Worcester, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-011-0177-xDOI Listing
March 2012

Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.

Cancer 2012 Aug 16;118(15):3743-8. Epub 2011 Dec 16.

Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26709DOI Listing
August 2012

Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma.

Cancer Causes Control 2011 Aug 22;22(8):1183-95. Epub 2011 Jun 22.

Department of Health Studies, University of Chicago, 5841 South Maryland Avenue, MC 2007, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-011-9797-5DOI Listing
August 2011

The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma.

Blood 2011 Jul 31;118(4):1052-61. Epub 2011 May 31.

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-03-340109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148157PMC
July 2011

Diffuse large B-cell lymphoma associated with the use of biologic and other investigational agents: the importance of long-term post-marketing safety surveillance.

J Drugs Dermatol 2011 Jan;10(1):80-3

Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
January 2011

Improving outcomes in PTLD.

Authors:
Andrew M Evens

Oncology (Williston Park) 2010 Sep;24(10):944, 946-7

Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
September 2010

Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.

Curr Oncol Rep 2010 Nov;12(6):383-94

Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-010-0132-1DOI Listing
November 2010

Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.

Clin Cancer Res 2010 Oct 26;16(19):4755-68. Epub 2010 Aug 26.

Department of Medicine, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948634PMC
October 2010